The Latest In Oxaloacetate Research

Alan Cash to Present Oxaloacetate CFS Clinical ...
Alan Cash, Chief Science Officer of Oxaloacetate CFS, will present the latest Oxaloacetate CFS clinical trial data at the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME) 2025 Virtual Research and...
Alan Cash to Present Oxaloacetate CFS Clinical ...
Alan Cash, Chief Science Officer of Oxaloacetate CFS, will present the latest Oxaloacetate CFS clinical trial data at the International Association of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (IACFS/ME) 2025 Virtual Research and...

New Long COVID Clinical Trial Shows Oxaloacetat...
August 2025 — SAN DIEGO, CA — A new randomized, double-blinded, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for Myalgic...
New Long COVID Clinical Trial Shows Oxaloacetat...
August 2025 — SAN DIEGO, CA — A new randomized, double-blinded, controlled clinical trial published in Frontiers in Neuroscience reveals promising results for Oxaloacetate CFS, a medical food for Myalgic...

FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...
FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...

International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...
International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...

Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...
Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...

International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...
International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...